Cor Vasa 2018, 60(1):e3-e8 | DOI: 10.1016/j.crvasa.2017.12.004

Panvascular disease - Epidemiology and prevention

Ileana Desormaisa,b, Charalambos Vlachopoulosc, Victor Aboyansb,d,*
a Department of Thoracic & Vascular Surgery and Vascular Medicine, Dupuytren University Hospital, Limoges, France
b Inserm 1094, Tropical Neuroepidemiology, Limoges University, Limoges, France
c 1st Department of Cardiology, National and Kapodistrian University of Athens, Greece
d Department of Cardiology, Dupuytren University Hospital, Limoges, France

Atherosclerosis is a progressive, general disease, affecting all arterial beds. Atherosclerosis starts in the youth [1] and aggravates in time, more or less quickly, according to the associated risk factors and genetic background.
The simultaneous presence of clinically relevant atherosclerotic lesions in at least two major vascular territories defines the multisite artery disease or panvascular disease (PVD).
This represents the situations where ischemic symptoms are present, concomitant, or successive during patient's history and/or in the presence of multiple subclinical arterial lesions at significant risk of clinical manifestation in the future, affecting two or more distinct territories.
The prevalence of PVD in general population is poorly studied but is sharply increasing with age and accumulation of common cardiovascular risk factors. Patients with PVD are at increased risk of further cardiovascular events, either fatal or nonfatal. In contrast, gaps in comprehensive care of these patients are frequent. Many studies are concordant to underline poorer management of these patients compared to single-bed artery disease, especially if there is no evidence of significant associated coronary artery disease.
Therefore, a full cardiovascular work-up should be proposed in a screening/preventive program in asymptomatic patients in order to primarily assess their cardiovascular risk.

Keywords: Epidemiology; Panvascular disease; Prevention

Received: October 7, 2017; Accepted: November 7, 2017; Published: February 1, 2018  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Desormais I, Vlachopoulos C, Aboyans V. Panvascular disease - Epidemiology and prevention. Cor Vasa. 2018;60(1):e3-8. doi: 10.1016/j.crvasa.2017.12.004.
Download citation

References

  1. A.W. Zieske, G.T. Malcom, J.P. Strong, Natural history and risk factors of atherosclerosis in children and youth: the PDAY study, Pediatric Pathology & Molecular Medicine 21 (2002) 213-237. Go to original source... Go to PubMed...
  2. V. Aboyans, J.B. Ricco, M.E.L. Bartelink, et al., 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS): document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries. Endorsed by: the European Stroke Organization (ESO) The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS), European Heart Journal 2017 Aug 26. doi: 10.1093/eurheartj/ehx095. [Epub ahead of print]. Go to original source... Go to PubMed...
  3. N. Savji, C.B. Rockman, A.H. Skolnick, et al., Association between advanced age and vascular disease in different arterial territories: a population database of over 3.6 million subjects, Journal of the American College of Cardiology 61 (2013) 1736-1743. Go to original source... Go to PubMed...
  4. D.L. Bhatt, P.G. Steg, E.M. Ohman, et al., International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis, Journal of the American Medical Association 295 (2006) 180-189. Go to original source... Go to PubMed...
  5. S. Subherwal, D.L. Bhatt, S. Li, et al., Polyvascular disease and long-term cardiovascular outcomes in older patients with non-ST-segment-elevation myocardial infarction, Circulation Cardiovascular Quality and Outcomes 5 (2012) 541-549. Go to original source... Go to PubMed...
  6. D. Mukherjee, K.A. Eagle, E. Kline-Rogers, et al., Impact of prior peripheral arterial disease and stroke on outcomes of acute coronary syndromes and effect of evidence-based therapies (from the Global Registry of Acute Coronary Events), American Journal of Cardiology 100 (2007) 1-6. Go to original source... Go to PubMed...
  7. F.G. Fowkes, L.P. Low, S. Tuta, J. Kozak, Ankle-brachial index and extent of atherothrombosis in 8891 patients with or at risk of vascular disease: results of the international AGATHA study, European Heart Journal 27 (2006) 1861-1867. Go to original source... Go to PubMed...
  8. CAPRIE Steering Committee, A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE), Lancet 348 (1996) 1329-1339. Go to original source... Go to PubMed...
  9. A.R. Naylor, Z. Mehta, P.M. Rothwell, P.R. Bell, Carotid artery disease and stroke during coronary artery bypass: a critical review of the literature, European Journal of Vascular and Endovascular Surgery 23 (2002) 283-294. Go to original source... Go to PubMed...
  10. J.C. Lin, L.S. Kabbani, E.L. Peterson, et al., Clinical utility of carotid duplex ultrasound prior to cardiac surgery, Journal of Vascular Surgery 63 (2016) 710-714. Go to original source... Go to PubMed...
  11. V. Aboyans, P. Lacroix, J. Guilloux, et al., A predictive model for screening cerebrovascular disease in patient undergoing coronary artery bypass grafting, Interactive Cardiovascular and Thoracic Surgery 4 (2005) 90-95. Go to original source... Go to PubMed...
  12. D.J. Durand, B.A. Perler, G.S. Roseborough, et al., Mandatory versus selective preoperative carotid screening: a retrospective analysis, Annals of Thoracic Surgery 78 (2004) 159-166, discussion 159-166. Go to original source... Go to PubMed...
  13. V. Aboyans, P. Lacroix, Indications for carotid screening in patients with coronary artery disease, Presse Medicale (Paris, France: 1983) 38 (2009) 977-986. Go to original source... Go to PubMed...
  14. A. Steinvil, B. Sadeh, Y. Arbel, et al., Prevalence and predictors of concomitant carotid and coronary artery atherosclerotic disease, Journal of the American College of Cardiology 57 (2011) 779-783. Go to original source... Go to PubMed...
  15. L. Razzouk, C.B. Rockman, M.R. Patel, et al., Co-existence of vascular disease in different arterial beds: peripheral artery disease and carotid artery stenosis - data from Life Line Screening ((R)), Atherosclerosis 241 (2015) 687-691. Go to original source... Go to PubMed...
  16. B. Ahmed, H. Al-Khaffaf, Prevalence of significant asymptomatic carotid artery disease in patients with peripheral vascular disease: a meta-analysis, European Journal of Vascular and Endovascular Surgery 37 (2009) 262-271. Go to original source... Go to PubMed...
  17. V. Aboyans, Polyvascular disease: definition, epidemiology, relevance, in: P. Lanzer (Ed.), Panvascular Medicine, vol. 2, Springer Berlin Heidelberg, Berlin, 2015, p. 4779-4810. Go to original source...
  18. S. Kownator, J.P. Cambou, P. Cacoub, et al., Prevalence of unknown peripheral arterial disease in patients with coronary artery disease: data in primary care from the IPSILON study, Archives of Cardiovascular Diseases 102 (2009) 625-631. Go to original source... Go to PubMed...
  19. A.T. Hirsch, M.H. Criqui, D. Treat-Jacobson, et al., Peripheral arterial disease detection, awareness, and treatment in primary care, Journal of the American Medical Association 286 (2001) 1317-1324. Go to original source... Go to PubMed...
  20. G. Agnelli, C. Cimminiello, G. Meneghetti, S. Urbinati, Low ankle-brachial index predicts an adverse 1-year outcome after acute coronary and cerebrovascular events, Journal of Thrombosis Haemostasis 4 (2006) 2599-2606. Go to original source... Go to PubMed...
  21. P. Morillas, J. Quiles, A. Cordero, et al., Impact of clinical and subclinical peripheral arterial disease in mid-term prognosis of patients with acute coronary syndrome, American Journal of Cardiology 104 (2009) 1494-1498. Go to original source... Go to PubMed...
  22. M.J. Makowsky, F.A. McAlister, P.D. Galbraith, et al., Lower extremity peripheral arterial disease in individuals with coronary artery disease: prognostic importance, care gaps, and impact of therapy, American Heart Journal 155 (2008) 348-355. Go to original source... Go to PubMed...
  23. M.J. Alberts, D.L. Bhatt, J.L. Mas, et al., Three-year follow-up and event rates in the international REduction of Atherothrombosis for Continued Health Registry, European Heart Journal 30 (2009) 2318-2326. Go to original source... Go to PubMed...
  24. Y. Imori, T. Akasaka, T. Ochiai, et al., Co-existence of carotid artery disease, renal artery stenosis, and lower extremity peripheral arterial disease in patients with coronary artery disease, American Journal of Cardiology 113 (2014) 30-35. Go to original source... Go to PubMed...
  25. E.K. Kim, P.S. Song, J.H. Yang, et al., Peripheral artery disease in Korean patients undergoing percutaneous coronary intervention: prevalence and association with coronary artery disease severity, Journal of Korean Medical Science 28 (2013) 87-92. Go to original source... Go to PubMed...
  26. A. Gallino, V. Aboyans, C. Diehm, et al., Non-coronary atherosclerosis, European Heart Journal 35 (2014) 1112-1119. Go to original source... Go to PubMed...
  27. I. Cho, H.J. Chang, J.M. Sung, et al., Coronary computed tomographic angiography and risk of all-cause mortality and nonfatal myocardial infarction in subjects without chest pain syndrome from the CONFIRM Registry (coronary CT angiography evaluation for clinical outcomes: an international multicenter registry), Circulation 126 (2012) 304-313. Go to original source... Go to PubMed...
  28. A.A. Hussein, K. Uno, K. Wolski, et al., Peripheral arterial disease and progression of coronary atherosclerosis, Journal of the American College of Cardiology 57 (2011) 1220-1225. Go to original source... Go to PubMed...
  29. M.P. Bonaca, D.L. Bhatt, R.F. Storey, et al., Efficacy and safety of Ticagrelor as long-term secondary prevention in patients with peripheral artery disease and prior myocardial infarction, Journal of the American College of Cardiology (2016). Go to original source...
  30. D. Calvet, E. Touze, O. Varenne, et al., Prevalence of asymptomatic coronary artery disease in ischemic stroke patients: the PRECORIS study, Circulation 121 (2010) 1623-1629. Go to original source... Go to PubMed...
  31. R. Hofmann, A. Kypta, C. Steinwender, et al., Coronary angiography in patients undergoing carotid artery stenting shows a high incidence of significant coronary artery disease, Heart 91 (2005) 1438-1441. Go to original source... Go to PubMed...
  32. M.G. Cohen, J.A. Pascua, M. Garcia-Ben, et al., A simple prediction rule for significant renal artery stenosis in patients undergoing cardiac catheterization, American Heart Journal 150 (2005) 1204-1211. Go to original source... Go to PubMed...
  33. V. Aboyans, B. Tanguy, I. Desormais, et al., Prevalence of renal artery disease and its prognostic significance in patients undergoing coronary bypass grafting, American Journal of Cardiology 114 (2014) 1029-1034. Go to original source... Go to PubMed...
  34. Y. Lee, J.H. Shin, H.C. Park, et al., A prediction model for renal artery stenosis using carotid ultrasonography measurements in patients undergoing coronary angiography, BMC Nephrology 15 (2014) 60. Go to original source... Go to PubMed...
  35. S. Bageacu, A. Cerisier, K. Isaaz, et al., Incidental visceral and renal artery stenosis in patients undergoing coronary angiography, European Journal of Vascular and Endovascular Surgery 41 (2011) 385-390. Go to original source... Go to PubMed...
  36. R.J. Valentine, J.D. Martin, S.I. Myers, et al., Asymptomatic celiac and superior mesenteric artery stenoses are more prevalent among patients with unsuspected renal artery stenoses, Journal of Vascular Surgery 14 (1991) 195-199. Go to original source... Go to PubMed...
  37. P.G. Steg, D.L. Bhatt, P.W. Wilson, et al., One-year cardiovascular event rates in outpatients with atherothrombosis, Journal of the American Medical Association 297 (2007) 1197-1206. Go to original source... Go to PubMed...
  38. W.M. Wilson, N. Andrianopoulos, D. Clark, et al., Long-term predictors of mortality after percutaneous coronary intervention in the era of drug-eluting stents, American Journal of Cardiology 108 (2011) 936-942. Go to original source... Go to PubMed...
  39. I. Graham, D. Atar, K. Borch-Johnsen, et al., European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts), European Heart Journal 28 (2007) 2375-2414.
  40. M.F. Piepoli, A.W. Hoes, S. Agewall, et al., 2016 European guidelines on cardiovascular disease prevention in clinical practice: the Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts): developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR), European Journal of Preventive Cardiology 23 (2016), NP1-NP96. Go to original source... Go to PubMed...
  41. S.S. Lim, T. Vos, A.D. Flaxman, et al., A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010, Lancet (London, England) 380 (2012) 2224-2260. Go to original source... Go to PubMed...
  42. P.B. Morris, B.A. Ference, E. Jahangir, et al., Cardiovascular effects of exposure to cigarette smoke and electronic cigarettes: clinical perspectives from the Prevention of Cardiovascular Disease Section Leadership Council and Early Career Councils of the American College of Cardiology, Journal of the American College of Cardiology 66 (2015) 1378-1391. Go to original source... Go to PubMed...
  43. L. Ryden, P.J. Grant, S.D. Anker, et al., ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD), European Heart Journal 34 (2013) 3035-3087. Go to original source...
  44. G.A. Antoniou, R.K. Fisher, G.S. Georgiadis, et al., Statin therapy in lower limb peripheral arterial disease: systematic review and meta-analysis, Vascular Pharmacology 63 (2014) 79-87. Go to original source... Go to PubMed...
  45. P.P. Aung, H.G. Maxwell, R.G. Jepson, et al., Lipid-lowering for peripheral arterial disease of the lower limb, Cochrane Database of Systematic Reviews (4) (2007) Cd000123. Go to original source...
  46. D.J. Kumbhani, P.G. Steg, C.P. Cannon, et al., Statin therapy and long-term adverse limb outcomes in patients with peripheral artery disease: insights from the REACH registry, European Heart Journal 35 (2014) 2864-2872. Go to original source... Go to PubMed...
  47. Authors/Task Force Members: A.L. Catapano, I. Graham, G. De Backer, et al., 2016 ESC/EAS guidelines for the management of dyslipidaemias, European Heart Journal 37 (2016) 2999-3058. Go to original source...
  48. G. Mancia, G. De Backer, A. Dominiczak, et al., 2007 guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC), Journal of Hypertension 25 (2007) 1105-1187. Go to original source... Go to PubMed...
  49. SPRINT Research Group: J.T. Wright Jr., J.D. Williamson, P.K. Whelton, et al., A randomized trial of intensive versus standard blood-pressure control, New England Journal of Medicine 373 (2015) 2103-2116. Go to original source... Go to PubMed...
  50. ONTARGET Investigators: S. Yusuf, K.K. Teo, J. Pogue, et al., Telmisartan, ramipril, or both in patients at high risk for vascular events, New England Journal of Medicine 358 (2008) 1547-1559. Go to original source...
  51. Heart Outcomes Prevention Evaluation Study Investigators, Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy, Lancet (London, England) 355 (2000) 253-259. Go to original source...
  52. J.W. Eikelboom, S.J. Connolly, J. Bosch, et al., Rivaroxaban with or without aspirin in stable cardiovascular disease, New England Journal of Medicine 377 (2017) 1319-1330. Go to original source... Go to PubMed...




Cor et Vasa

You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.